Chemically-induced disorders

Clinical trials for Chemically-induced disorders explained in plain language.

Never miss a new study

Get alerted when new Chemically-induced disorders trials appear

Sign up with your email to follow new studies for Chemically-induced disorders, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Terminated 1

Magic mushroom compound tested for meth addiction – but trial stopped early

Symptom relief Stopped early

This study tested whether psilocybin, the active ingredient in magic mushrooms, is safe and feasible for people with methamphetamine use disorder. Only 5 participants were enrolled, and the trial was terminated early, so the results are very limited. The goal was to see if psiloc…

Matched conditions: CHEMICALLY-INDUCED DISORDERS

Phase 1 • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief

Last updated Jun 27, 2026 12:31 UTC

Chemically-induced disorders

Get alerted when new Chemically-induced disorders trials appear

Magic mushroom compound tested for meth addiction – but trial stopped early